News

19

Nov, 2021

In Memory of Dr Scott M. Hammer

Tags:

With a great sadness I learnt today that Scott passed away. The IAS obituary says everything about him as a great scientist. I just would like to remember him as a very good friend who cared about children throughout his professional life. In 2006 we chaired together the WHO working group to develop the guidelines for antiretroviral  therapy “Toward universal access”. Scott has been mentoring me in an unforgettable way ! Carlo Giaquinto on behalf of Penta ______________________________________________________________________________________ The IAS-USA is deeply saddened by the passing of Dr Scott M. […]

READ MORE

15

Nov, 2021

VERDI project launches

Tags: , , ,

Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI, a new European research consortium on coronavirus in children and pregnant women. Carlo Giaquinto, Professor at University of Padova and President of Penta, together with Professor Ali Judd at University College London, will be the scientific coordinators of VERDI.   Padova, Italy – 15 November 2021 Children and pregnant women have taken a back seat during the COVID-19 pandemic. With children most likely to be the last to be […]

READ MORE

12

Nov, 2021

World Pneumonia Day 2021: Every breath counts

Tags: , ,

It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives that are lost daily to chest infections (pneumonia). According to UNICEF, pneumonia is the single largest cause of death in children under five and the majority of these deaths occur in low- and middle-income countries. Pneumonia needn’t be the deadly infectious disease that it is today. Through immunization, nutritional interventions, and controlling environmental risk factors the burden of child pneumonia can be […]

READ MORE

29

Oct, 2021

ODYSSEY trial wins 2021 Hector Award

Tags: , ,

It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf of the ODYSSEY trial team! The winning paper Simplified dolutegravir dosing for children with HIV weighting 20kg or more pharmacokinetic and safety substudies of the multicentre randomised ODYSSEY trial, can be found here. Congratulations to the entire study team and thank you to all the families and children who participated in the ODYSSEY trial. Sponsored by Penta and funded by […]

READ MORE

28

Sep, 2021

Dolutegravir-based ART is superior to NNRTI- and PI-based ART in infants, children and adolescents living with HIV (combined results of the main trial and the ‘under 14kg’ cohort)

 

Authors: Anna Turkova on behalf of the ODYSSEY trial team Presented at: CHIVA 2021   Abstract ODYSSEY Internationalmulti-centre,randomised96-weeknon- inferiority trial WeaimedtocompareefficacyandsafetyofDTG-basedART with standard-of-care in children and adolescents starting first-line ART (ODYSSEY A) or second-line (ODYSSEY B) Main trial enrolled children≥14kg Aim to enrol ≥700 children: 310 ODYSSEY A, 390 ODYSSEY B Powered for efficacy (total population and A&B separately) Once enrolment in the main trial was completed, the trial was opened for ‘under 14kg cohort’ ‘Under 14kg’ cohort Aim to enrol ≥20 children in each of the three lower WHO […]

READ MORE

20

Sep, 2021

PentaTr@ining kicks off HIV and other Congenital Infections course, in Spanish

Tags:

The Spanish language version of our online course “PentaTr@ining: HIV and other Congenital Infections” kicks off today! We look forward to welcoming over 100 participants for this year’s edition of our newly upgraded online training course. Unique in its design and delivery, ‘PentaTr@ining’ is an innovative training platform which continues to develop and evolve in response to the changing needs of children, young people and pregnant women living with HIV and other congenital infections. Our flagship online course is highly interactive and clinical case based, designed to kindle engagement and […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities